AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart …

SC Smith Jr, J Allen, SN Blair, RO Bonow, LM Brass… - Circulation, 2006 - Am Heart Assoc
• Ask about tobacco use status at every visit. I (B)• Advise every tobacco user to quit. I (B)•
Assess the tobacco user's willingness to quit. I (B)• Assist by counseling and developing a …

AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the …

SC Smith Jr, EJ Benjamin, RO Bonow, LT Braun… - Circulation, 2011 - Am Heart Assoc
(ACCF) guidelines on secondary prevention, 1 important evidence from clinical trials has
emerged that further supports and broadens the merits of intensive risk-reduction therapies …

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task …

RH Eckel, JM Jakicic, JD Ard, JM de Jesus, NH Miller… - Circulation, 2014 - Am Heart Assoc
The goals of the American College of Cardiology (ACC) and the American Heart Association
(AHA) are to prevent cardiovascular diseases (CVDs); improve the management of people …

AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients …

TA Pearson, SN Blair, SR Daniels, RH Eckel, JM Fair… - Circulation, 2002 - Am Heart Assoc
The initial Guide to the Primary Prevention of Cardiovas-cular Diseases was published in
1997 as an aid to healthcare professionals and their patients without established coronary …

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart …

DK Arnett, RS Blumenthal, MA Albert… - Journal of the American …, 2019 - jacc.org
Although there has been substantial improvement in atherosclerotic cardiovascular disease
(ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …

Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease

LK Newby, NM Allen LaPointe, AY Chen, JM Kramer… - Circulation, 2006 - Am Heart Assoc
Background—Studies have examined the use of evidence-based therapies for coronary
artery disease (CAD) in the short term and at hospital discharge, but few have evaluated …

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force …

DK Arnett, RS Blumenthal, MA Albert, AB Buroker… - Circulation, 2019 - Am Heart Assoc
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of
the American College of Cardiology/American Heart Association Task Force on Clinical …

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: part 1, lifestyle and behavioral factors

DK Arnett, A Khera, RS Blumenthal - JAMA cardiology, 2019 - jamanetwork.com
Summary of the Clinical Problem Atherosclerotic cardiovascular disease (ASCVD) remains
the leading cause of death in the United States. Most individuals who develop ASCVD have …

Drugs for primary prevention of atherosclerotic cardiovascular disease: an overview of systematic reviews

KN Karmali, DM Lloyd-Jones, MA Berendsen… - JAMA …, 2016 - jamanetwork.com
Importance The Million Hearts initiative emphasizes ABCS (aspirin for high-risk patients,
blood pressure [BP] control, cholesterol level management, andsmoking cessation) …

Get with the guidelines for cardiovascular secondary prevention: pilot results

KA LaBresh, AG Ellrodt, R Gliklich… - Archives of Internal …, 2004 - jamanetwork.com
Background The use of Web-based technology and a collaborative model to improve
hospital adherence to secondary prevention guidelines has not been previously evaluated …